Prospective Assessment of HPV Associated Anogenital Pathology in Female Patients and Female Partners of Patients With Confirmed HPV Associated Oropharyngeal Carcinoma, PAP-OP Study

Recruiting now

Conditions studied: Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma

In brief

This study evaluates how often women with throat (oropharyngeal) cancer or who have a partner with oropharyngeal cancer get anogenital infections with high risk, potentially cancer-causing types of human papilloma virus (HPV).

Key facts

Study ID

NCT06115772

Run by

Mayo Clinic

People needed

154

Starts

2022-11-01

Expected to finish

2027-11-01

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• * Female patients with diagnosed HPV(+)OPSCC seen at the Mayo Clinic, Rochester
• Age ≥ 18
• Female partners of Mayo Clinic patients with diagnosed HPV(+)OPSCC
• Patient has given permission to give his/her blood/saliva sample for research testing
• Ability to complete questionnaire(s) by themselves or with assistance

You may not qualify if…

• * HPV(-) OPSCC
• Unable to provide informed consent
• Unwilling to attend screening visit at Mayo Clinic site, if indicated
• Unwilling/unable to complete surveys electronically

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.